Identifying the gene causing Congenital Short Bowel Syndrome
Completed
- Conditions
- Congenital Short Bowel Syndrome1008362410017977
- Registration Number
- NL-OMON35033
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 3
Inclusion Criteria
Patient: Diagnosis of Congenital Short Bowel Syndrome
Family member: Being a family member of a patient with Congenital Short Bowel Syndrome
Exclusion Criteria
Patient: Not a diagnosis of Congenital Short Bowel Syndrome
Family member: not being a family member of a patient with Congenital Short Bowel Syndrome
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Identification of the causative gene for CSBS</p><br>
- Secondary Outcome Measures
Name Time Method <p>Geen</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What genetic mutations are associated with Congenital Short Bowel Syndrome in the NL-OMON35033 observational study?
How does the identified gene in NL-OMON35033 contribute to intestinal development and CSBS pathogenesis?
Are there biomarkers for CSBS severity or prognosis derived from the UMC Groningen gene discovery research?
What molecular pathways are disrupted by the causative gene in Congenital Short Bowel Syndrome cases?
How might findings from NL-OMON35033 inform gene therapy approaches for neonatal intestinal insufficiency?